STXS · Stereotaxis, Inc. · Webcasts, Transcripts & Audio
$0.91
-0.06 (-6.21%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$96.93M
Shares
100.20M
Volume · Oct 29
810.41K
Avg daily vol (3M)
579.18K
Stereotaxis, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Stereotaxis, Inc. (STXS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-11
Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript
Confident tone
Genesis X robotic platform
Catheter portfolio and magic
Synchrony system launch
Revenue
$7.67M
▼ 12.8% YoY Diluted EPS
$-0.05
Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Stereotaxis, Inc. (STXS) Q1 2026 Earnings Call Transcript
Confident tone
MAGIC catheter commercial launch
Disposable revenue transformation
Regulatory approvals (FDA and international)
Revenue
$6.29M
▼ 15.8% YoY Diluted EPS
$-0.06
Gross margin
60.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-09
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Confident tone
Regulatory milestones for next-gen products
Digital / platform expansion and new indications
China opportunity with MicroPort
Revenue
$8.64M*
▲ 36.3% YoY Gross margin
50.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript
Confident tone
Robotic System Sales and Backlog
MAGiC U.S. Regulatory Path
GenesisX System Launch and FDA Approval
Revenue
$7.46M
▼ 18.8% YoY Diluted EPS
$-0.07
Gross margin
54.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-17
Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript
Confident tone
MAGiC ablation catheter
Financial performance and growth outlook
GenesisX robot launch
Revenue
$8.80M
▲ 95.4% YoY Diluted EPS
$-0.05
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call
Confident tone
Regulatory approvals for new product ecosystem
Johnson & Johnson legacy transition headwinds
Genesis X capital system launch
Revenue
$7.47M
▲ 8.6% YoY Diluted EPS
$-0.07
Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-03
Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript
Confident tone
MAGIC Ablation Catheter Commercialization
MAGIC Sweep Mapping Catheter
Regulatory Pathway and FDA
Revenue
$6.34M*
▲ 38.9% YoY Gross margin
50.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript
Confident tone
Genesis and Genesis X robotic systems
APT acquisition and catheter recurring revenue
Mapping and guide catheter development
Revenue
$9.20M
▲ 17.9% YoY Diluted EPS
$-0.08
Gross margin
44.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Stereotaxis, Inc. (STXS) Q2 2024 Earnings Call Transcript
Positive tone
Capital revenue weakness and backlog
GenesisX next-generation platform
China market and regulatory
Revenue
$4.50M
▼ 42.7% YoY Diluted EPS
$-0.07
Gross margin
73.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Stereotaxis, Inc. (STXS) Q1 2024 Earnings Call Transcript
Confident tone
APT Acquisition and Integration
Revenue and Backlog Growth
MAGiC Ablation Catheter Regulatory Progress
Revenue
$6.88M
▲ 5.1% YoY Diluted EPS
$-0.06
Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
Stereotaxis, Inc. (STXS) Q4 2023 Earnings Call Transcript
Confident tone
Revenue Performance and Volatility
MAGiC Catheter (Proprietary Ablation Catheter)
Robotic System (Genesis / Mobile / Next-Gen)
Revenue
$4.57M*
▼ 37.5% YoY Gross margin
60.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
Stereotaxis, Inc. (STXS) Q3 2023 Earnings Call Transcript
Revenue
$7.80M
▲ 1.9% YoY Diluted EPS
$-0.07
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
Stereotaxis, Inc. (STXS) Q2 2023 Earnings Call Transcript
Revenue
$7.86M
▲ 27.7% YoY Diluted EPS
$-0.07
Gross margin
53.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Stereotaxis, Inc. (STXS) Q1 2023 Earnings Call Transcript
Revenue
$6.55M
▼ 6.9% YoY Diluted EPS
$-0.07
Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-03
Stereotaxis, Inc. (STXS) Q4 2022 Earnings Call Transcript
Revenue
$7.30M*
▼ 11.4% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Stereotaxis, Inc. (STXS) Q3 2022 Earnings Call Transcript
Revenue
$7.66M
▼ 15.9% YoY Diluted EPS
$-0.07
Gross margin
59.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Stereotaxis, Inc. (STXS) Q2 2022 Earnings Call Transcript
Revenue
$6.15M
▼ 32% YoY Diluted EPS
$-0.07
Gross margin
75.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Stereotaxis, Inc. (STXS) Q1 2022 Earnings Call Transcript
Revenue
$7.04M
▼ 18.4% YoY Diluted EPS
$-0.06
Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Stereotaxis, Inc. (STXS) Q4 2021 Earnings Call
Revenue
$8.24M*
▲ 20.8% YoY Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Stereotaxis, Inc. (STXS) Q3 2021 Earnings Call
Revenue
$9.11M
▲ 4.6% YoY Diluted EPS
$-0.07
Gross margin
52.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Stereotaxis, Inc. (STXS) Q2 2021 Earnings Call
Revenue
$9.05M
▲ 69.3% YoY Diluted EPS
$-0.02
Gross margin
72.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
Stereotaxis, Inc. (STXS) Q1 2021 Earnings Call
Revenue
$8.62M
▲ 49.8% YoY Diluted EPS
$-0.02
Gross margin
69.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Stereotaxis, Inc. (STXS) Q4 2020 Earnings Call Transcript
Revenue
$6.82M*
▼ 1% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Stereotaxis, Inc. (STXS) Q3 2020 Earnings Call Transcript
Revenue
$8.70M
▲ 6.1% YoY Diluted EPS
$-0.03
Gross margin
53.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Stereotaxis, Inc. (STXS) Q2 2020 Earnings Call Transcript
Revenue
$5.35M
▼ 21.4% YoY Diluted EPS
$-0.03
Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Stereotaxis, Inc. (STXS) Q1 2020 Earnings Call Transcript
Revenue
$5.76M
▼ 17.9% YoY Diluted EPS
$-0.03
Gross margin
83.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-10
Stereotaxis, Inc. (STXS) Q4 2019 Earnings Call
Revenue
$6.89M*
▼ 5.2% YoY Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 webcasts
Key facts
CIK
1289340
CUSIP
85916J409
13F (30d)
18 filings
18 filers
Visit website
Investor relations